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ABSTRACT

NEURONAL AND MOLECULAR ADAPTATIONS OF GABA NEURONS
IN THE VENTRAL TEGMENTAL AREA TO CHRONIC ALCOHOL

Kimberly Hales
Department of Physiology and Developmental Biology
Master of Neuroscience

The purpose of this thesis project was to examine the effects of chronic alcohol on
the excitability and molecular adaptation of GABA neurons of the ventral tegmental area
(VTA).

GABA neurons are of interest with regards to ethanol intoxication,

reinforcement, and dependence due to their widespread distribution and connectivity to
mesocorticolimbic dopamine (DA) neurons implicated in alcohol reward and addiction.
Since we have previously shown adaptation of VTA GABA neuron firing rate to chronic
ethanol (Gallegos, Criado et al. 1999) and suppression of gap-junction (GJ) mediated
coupling between these neurons by acute ethanol (Stobbs, Ohran et al. 2004), we wanted
to further characterize the effects of chronic ethanol on VTA GABA neuron excitability,
electrical coupling and molecular adaptation. In particular, we analyzed the GJ mediated
coupling and protein regulation of VTA GABA neurons following a three week period of
continuous ethanol exposure via liquid diet. Although some animals showed tolerance,

there was no significant tolerance to ethanol inhibition of GJ-mediated electrical
coupling. In addition, we were able to characterize differences in mRNA expression
levels for the DA synthesizing enzyme tyrosine hydroxylase (TH), the DA D2 receptor
and the NMDAR2B receptor subunit in DA versus GABA neurons, all three of which
were expressed at higher levels in DA neurons. We also determined the effects of
chronic ethanol on mRNA levels of these same proteins as well as µ-opioid receptors
(µORs) and connexin-36 (Cx36) GJs. Most significantly, we found a down-regulation of
the DA D2 receptor, confirming that molecular modification occurs in these VTA GABA
neurons with chronic alcohol.

While we reject our hypothesis that acute ethanol

inhibition of VTA GABA neuron electrical coupling would undergo tolerance to chronic
ethanol in these non-dependent rats, which was the focus of this thesis, it remains to be
determined if tolerance to chronic ethanol might be obtained in ethanol-dependent rats.
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NEURONAL AND MOLECULAR ADAPTATIONS OF GABA NEURONS IN THE
VENTRAL TEGMENTAL AREA TO CHRONIC ALCOHOL
Kimberly Hales

INTRODUCTION

The field of alcohol research is devoted to a vast conglomeration of labs across
the country and world. One main reason for this is the wide-spread use and abuse of this
psychoactive drug that results in billions of dollars of damage and millions of deaths each
year. Alcohol addiction is an area of focus worth studying due to its global impact,
biological nature, abuse potential and long-term relapsing effects. The tolerance and
dependence that comes from repeated chronic use is of particular interest to me and its
biological implications are the focus of my project. The rationale for this study is
predicated on the belief that advancement in the understanding of the neuronal substrates
underlying the acute and chronic effects of alcohol will pave the way for more effective
treatment strategies for alcoholism that would save lives and resources throughout the
world. There were two main goals in this study: 1) Evaluate whether gap junctions (GJs)
and electrical coupling in the ventral tegmental area (VTA) of the midbrain, an area
implicated in natural rewarding behaviors and drug addiction, play a role in the
adaptation process that occurs during the transition from the acute effects of alcohol, to
relapse, and then to dependence, and 2) Assess the regulation of key proteins in the VTA
following chronic alcohol use. My principal hypothesis was that electrical coupling in
VTA GABA neurons is involved in the acute effects of ethanol and that changes in GJ
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function might play a role in the progressive increase in the motivation to seek alcohol.
In addition, I predicted that protein expression in this population of VTA neurons would
be modified with chronic alcohol.

In this thesis I will: 1) Briefly review the

mesocorticolimbic reward system and discuss the current state of knowledge regarding
alcoholism; 2) Review the neural circuits implicated in the acute and chronic effects of
alcohol; 3) Describe the neurobiology of GJs and evidence for DA modulation of GJs; 4)
Summarize the research regarding VTA GABA neurons and their role in the
mesocorticolimbic DA system; 5) Present our experimental results, and 6) Discuss the
implications of these results while providing an overview of critiques to help in future
studies.

BACKGROUND

The mesocorticolimbic system is an area in the brain known to be involved with
natural and drug reward as well as addiction. Within this system, many different parts of
the brain are linked by pathways, including the hippocampus, amygdala, medial
prefrontal cortex, nucleus accumbens and ventral tegmental area (Pierce and Kumaresan
2006). The ventral tegmental area (VTA) and nucleus accumbens (NAcc) are considered
to be reward centers that are affected by alcohol. Within the VTA, there are two main
types of neurons: Dopamine (DA) and GABA. Pathways from both of these types of
neurons are sent to other parts of the limbic system and in turn, the VTA receives
GABAergic input from the NAcc. Dopamine and GABA neurons have distinctive firing
patterns in anesthetized adult male rats. Dopamine neurons fire slowly and sometimes in
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bursts while GABA neurons fire at a much higher frequency and do not fire in bursts
(Steffensen, Svingos et al. 1998). Using this distinctive firing pattern of these neurons,
we are able to distinguish between the two relatively easily in the brain in vivo.
The prevailing dogma behind reward and addiction in the brain is that a euphoric
state is achieved through increased DA levels in the mesocorticolimbic system,
particularly the NAcc and the VTA (Wise 2004). Thus, much of the drug and alcohol
research has been dedicated to studying DA neurons in this system of the brain.
Interestingly, rats will self-administer ethanol directly into the VTA (Gatto, McBride et
al. 1994) and an ethanol-induced increase of DA release in the NAcc, detected by
microdialysis, has been reported extensively (Imperato and DiChiara 1986; Wozniak,
Pert et al. 1991; Yoshimoto, McBride et al. 1992) (see also (Di Chiara and Imperato
1985; Di Chiara and Imperato 1988; Weiss 1991; Weiss, Hurd et al. 1991)). While
activation of the mesocorticolimbic system is implicated in drug reward, the DA
component of the system is critical only for psychostimulant reward (Koob 1996), as rats
continue to self-administer ethanol as well as opioids with severe neurotoxin-lesions of
the mesocorticolimbic DA system (Koob 1992). Thus the focus of our lab is on the
GABA neurons in the VTA.
We believe that GABA neurons synapse on DA neurons in the VTA, thereby
providing an inhibitory input to regulate DA release. This is in agreement with the
previous finding of GABAergic control over DA neurons in the substantia nigra (Tepper,
Paladini et al. 1998), a structure involved more with motor activity than psychomotor
activity, but analogous to the VTA. Inhibition of these inhibitory GABA neurons would
result in hyperexcitability of DA neurons and an increased amount of DA release. This is
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in line with the DA theory mentioned above. Previously, it has been shown that alcohol
decreases the firing rate of these GABA neurons with acute administration for up to 2
weeks (Gallegos, Criado et al. 1999). In line with our theory and the DA theory, the
decreased firing rate of the GABA neurons would result in more DA to be released and a
euphoric state would result. After 2 weeks of daily alcohol administration however, the
firing rate no longer decreases (Gallegos, Criado et al. 1999).

This indicates that

tolerance is occurring with these neurons, resulting in hyperactivity of the GABA
neurons and thus a decrease in DA release that leads to a withdrawal state once alcohol is
out of the system.
Another interesting phenomenon we have previously shown is that highfrequency stimulation of the internal capsule (IC) causes multiple spike discharge
(ICPSDs) of GABA neurons in the VTA (Steffensen, Svingos et al. 1998).

These

discharges are blocked by gap junction (GJ) antagonists, suggesting that ICPSDs are a
physiological manifestation of GJ-mediated electrical coupling between VTA GABA
neurons (Steffensen, Stobbs et al. 2003).

Ethanol suppresses VTA GABA neuron

ICPSDs, with an IC50 at a dose of 1.1 g/kg of ethanol (Stobbs, Ohran et al. 2004), a
moderately intoxicating dose. Thus, in addition to ethanol affecting the firing rate of
VTA GABA neurons, it appears that ethanol is also affecting the ability of these neurons
to couple electrically. Given the previous work done in ours and other’s labs, the main
focus

of

my

project

was

to

further

characterize

these

GABA

neurons

electrophysiologically and molecularly with chronic alcohol administration.
There are six proteins that were analyzed using RT-PCR: Connexin-36 (Cx36),
Scn4b, DA D2 receptor, µ-opioid receptor (µOR), NMDAR2B (NR2B), and tyrosine
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hydroxylase (TH). I will briefly go over the rationalization for studying each of these
proteins by showing their correlation with alcohol. The first is Cx36, a GJ protein that
we have previously found to be expressed by GABA neurons in the VTA (Allison, Ohran
et al. 2006). Interestingly, just as ethanol blocks GABA neuron ICPSDs, quinidine, a
non-selective GJ antagonist, and mefloquine, a selective Cx36 junction antagonist, also
block ICPSDs.

We don’t necessarily believe ethanol is acting through the same

mechanism, by blocking the GJs, but knowing whether this protein is being up or down
regulated is of significant importance, suggesting changes in the GABA neuron electrical
network.
Scn4b is a recently discovered β-subunit of the voltage-gated sodium channel that
appears to play a role in the functional aspect of channel activation (Yu, Westenbroek et
al. 2003). The gene for this protein has also been found to be correlated with strong
alcohol preference in mice (Mulligan, Ponomarev et al. 2006). While this role seems to
deal more with alcoholism rather than chronic alcohol abuse, we wanted to see if this βsubunit is expressed in VTA GABA and/or DA neurons and if it changes over time with
ethanol exposure.
Dopamine, as we have seen thus far, plays an important role in the
mesocorticolimbic system. Acute, local administration of DA activates GABA neurons,
increasing their firing rate 100-200% (Stobbs, Ohran et al. 2004). This activation has
been shown in our lab recently to be occurring through the D2 receptor, given that
antagonists block this activation. As acute ethanol decreases the firing rate of VTA
GABA neurons, but chronic ethanol increases their firing rate, it would seemed logical to
look at expression levels of this protein to see if it is also affected with chronic ethanol.
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Opioids have long been associated with reward in the brain. Thus, it is not
surprising that receptors for µ-opioid receptors (µORs) are located within the
mesocorticolimbic system. The subpopulation of VTA GABA neurons that we study
expresses µORs (Steffensen, Stobbs et al. 2006). Work has been done showing that an
acute dose of ethanol in vivo causes a reduction of µOR binding in the nucleus
accumbens and VTA 1 hour after administration with an increase in binding in the
frontal/prefrontal cortices 2 hours after administration (Mendez, Leriche et al. 2001).
Many current investigations in alcohol research focus on determining associations
between endogenous opioid systems and alcohol. In fact, one of the newest therapies for
alcohol craving is naltrexone, an opioid antagonist. Thus the goal was to see what
changes might occur in µOR expression with chronic ethanol.
Tyrosine

hydroxylase

is

an

enzyme

involved

in

the

formation

of

dihydroxyphenylalanine, a precursor to DA. Twelve week exposure to liquid diet with
alcohol increased tyrosine hydroxylase in the VTA (Ortiz, Fitzgerald et al. 1995). Our
reasoning for looking at this protein was to compare expression levels after a shorter
exposure to ethanol compared to Ortiz et al using western blot analysis and to have a key
molecular marker for distinguishing neuronal type in the aspirated cells when performing
RT-PCR.
The final protein analyzed by RT-PCR was NMDAR2B. The NMDA receptor is
made up of NR1 and NR2 subunits. There are four types of NR2 subunits (A-D) and it is
the NR2B subunit that has been implicated the most with alcohol. While one study
showed that after 10-12 days of ethanol exposure, no NR1 and NR2B mRNA or protein
level changes were seen in the amygdala (Lack, Floyd et al. 2005), it has also been shown

6

that NR1, NR2A and NR2B showed elevated levels in hippocampal explants after
chronic exposure to 75 mM ethanol (Hendricson, Maldve et al. 2007). It would be
expected to see an up-regulation of NMDA receptors in general given that ethanol
inhibits NMDA receptors (Harris 1999).

In addition it has been shown that

developmental decreases in ethanol inhibition of NMDA receptor function in rat cortical
neurons parallel developmental decreases in inhibition by ifenprodil, in which the NR2B
subunit is essential for its action (Lovinger 1995).

Since we also believe NMDA

receptors are involved with ethanol suppression of GABA neuron ICPSDs (Stobbs,
Ohran et al. 2004), additional characterization was needed to further determine their role
in acute and chronic ethanol models.
In addition to analyzing these six proteins through RT-PCR, we analyzed some of
these proteins through western blotting. We were able to obtain reliable antibodies for
TH, NMDAR2B, Cx36 and GAD-6. GAD, glutamic acid decarboxylase, is an enzyme
that cataylzes the decarboxylation of glutamate to form GABA, the main neurotransmitter
released in GABA. Though we were not able to analyze GAD via RT-PCR, we did have
an antibody for this protein and opted to analyze the level of expression in the VTA,
NAcc and whole rat brain.

HYPOTHESES

Since we had previously demonstrated that tolerance accrues to ethanol inhibition
of VTA GABA neuron firing rat (Gallegos et al., 1999), and that acute ethanol inhibits
coupling between VTA GABA neurons (Stobbs et al., 2004), I hypothesized that
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tolerance would accrue to ethanol inhibition of electrical coupling between VTA GABA
neurons. Since others had shown that critical gene products adapt during chronic ethanol
(e.g., TH), I hypothesized that some of the gene products that we had chosen (other than
TH) would adapt as well. Specifically, given the well-known rapid adaptability of µORs
demonstrated in other systems (Bailey and Connor 2005), the fact that VTA GABA
neurons contain µORs and that the firing rate of VTA GABA neurons is markedly
inhibited by µOR agonists (Steffensen, Stobbs et al. 2006), I predicted that µOR
expression would be up-regulated in chronic ethanol treated rats. Since Cx36 expression
has been shown to up-regulate in association with cocaine treatment (Bennett, Arnold et
al. 1999), and VTA GABA neurons express Cx36, I hypothesized that Cx36 expression
would be up-regulated as well to chronic ethanol. D2 receptors appear to be mostly
involved in auto-receptor inhibition of DA neurons. Thus, since D2 receptor activation
by DA clearly excites VTA GABA neurons I hypothesized that it might be a critical
substrate for adaptation to chronic ethanol.

METHODS

Animal Procedures

Male Sprague-Dawley rats were bred and cared for in accordance with the
National Institutes of Health Guide for the Care and Use of Laboratory Animals. Once
weighing 140-160 g (34-38 days old), they were housed separately and given ad libitum
access to solid food, water and a commercially available liquid diet (Dyets, Bethlehem
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PA), known as the Lieber-DeCarli diet (Lieber and DeCarli 1989). The liquid diet was
made up fresh every few days in a blender and stored at 4ºC. After one day, the solid diet
and water was removed and rats were divided into two groups, control and chronic
ethanol. The following day, the control group received the standard liquid diet and the
chronic ethanol group received an ethanol-containing diet. Due to the natural aversion of
rats to ethanol, the rats in the latter group were introduced to the ethanol by increasing the
percentage of ethanol in three increments over five days (3-5%). To accommodate for
reduced food intake, the chronic ethanol rats were pair-fed with the control group to
maintain equal caloric intakes in both groups, with the control group only receiving the
amount their pair-fed chronic ethanol rat consumed the previous day.

In addition,

maltose dextrin was added to the control diet to make the diet iso-caloric with the ethanol
diet. Once the chronic ethanol group reached an ethanol level of 5% in their liquid diet,
they were maintained at this concentration for 2-3 weeks. Both control and ethanol liquid
diets were changed daily at 5:00pm. Prior to in vivo electrophysiology experiments,
chronic ethanol rats were withdrawn from ethanol for a period of 3-24 hours, depending
on the group.

Surgical Procedure and Electrophysiology

For acute electrophysiological recordings of VTA GABA neurons, the rats were
anesthetized using isoflourane and placed in a stereotaxic apparatus. Body temperature
was maintained at 37.4 ± 0.4ºC by a feedback regulated heating pad. With the skull
exposed, holes were drilled for placement of stimulating and recording electrodes.
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Extracellular potentials were recorded by 3.0 M KCl-filled micropipettes (2-4 MΩ; 1 µm
inside diameter). Potentials were amplified with an Axon Instruments Multiclamp 700A
amplifier (Union City, CA). Microelectrodes were oriented, via stereotaxic coordinates,
into the VTA (from bregma: 5.6 - 6.5 posterior (P), 0.5 - 1.0 lateral (L), 6.5 - 7.5 ventral
(V)) with a piezoelectric microdrive (EXFO Burleigh 8200 controller and Inchworm,
Victor, NY).

Single-unit activity was filtered at 0.3-10 kHz (-3dB) for "filtered"

recordings and 0.1 Hz - 10 kHz for "unfiltered" recordings with the Multiclamp 700A
amplifier and displayed on Tektronix (Beaverton, OR) digital oscilloscopes. Potentials
were sampled at 20 kHz (12 bit resolution) with National Instruments data acquisition
boards in Macintosh computers (Apple Computer, Cupertino, CA).

Extracellularly-

recorded action potentials were discriminated with a World Precision Instruments WP121 Spike Discrimator (Sarasota, Fl) and converted to computer-level pulses. Single-unit
potentials, discriminated spikes and stimulation events were captured by National
Instruments NB-MIO-16 digital I/O and counter/timer data acquisition boards (Austin,
TX) in Macintosh computers.
VTA GABA neurons were identified by previously-established stereotaxic
coordinates and by electrophysiological criteria (Steffensen, Svingos et al. 1998). They
included: relatively fast firing rate (>10Hz); ON-OFF phasic non-bursting activity; spike
duration less than 250 µsec; and multiple post-stimulus spike discharges (PSDs)
produced by stimulation of the internal capsule (-1.0-1.3 P, 2.3-3.0 L, 5.0-6.0 V). We
evaluated only those spikes that had greater than 4:1 signal-to-noise ratio.
Corticotegmental activation of VTA GABA neurons was accomplished by stimulation of
the internal capsule (IC) with insulated, bipolar stainless steel electrodes. This activation
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of VTA GABA neuron spikes is referred to as IC stimulus-induced PSDs (ICPSDs).
Square-wave constant current stimulus pulses (50-2000 µA; 0.15 ms duration; average
frequency, 0.1 Hz) were generated by an AMPI IsoFlex isolation unit controlled by an
AMPI MASTER-8 Pulse Generator (Jerusalem, Israel) or by computer. Stimulation was
performed at an intensity that produced 50% maximum VTA GABA neuron ICPSDs
with 10 pulses at 200 Hz (Steffensen, Svingos et al. 1998; Steffensen, Stobbs et al. 2003).
Systemic administration of 1.0 g/kg ethanol (16% ethanol in saline) was accomplished by
intraperitoneal injections.

Analysis of Responses

Discriminated spikes and stimulation events were processed with National
Instruments LabVIEW and IGOR Pro software (Wavemetrics, Lake Oswego, OR). Peristimulus spike histograms (PSHs) were constructed for determinations of the number of
VTA GABA neuron ICPSDs.

The histograms were normalized to number of IC

stimulations before and after drug treatment (12 stimulation trains at 10 sec intervals, 1
sec epoch, 2 ms bin width). The number of driven spikes following IC stimulation was
determined by rectangular integration using IGOR Pro software. As the number of
discharges varies across neurons within each animal and across animals, we integrated
spikes on PSHs falling in bins immediately after the stimulation epoch and extending to a
point on the PSH where the discharges appeared to be just above the floor of spontaneous
activity (range between 250-600 ms beyond the stimulus artifact). To further reduce
variability across treatment groups, we standardized ICPSDs to percent control. The
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results for control and chronic ethanol groups were derived from calculations performed
on PSHs and expressed as means ± S.E.M. The results were then compared between
ethanol diet and pair-fed control groups using the paired two-sample for means t-test.

Tissue Sectioning

After the in vivo electrophysiology was performed, the rats were anesthetized and
decapitated. The brain was quickly removed and placed in ice-cold slushy artificial
cerebral spinal fluid (ACSF) (124 mM NaCl, 2 mM KCl, 1.25 mM NaH2PO4-H2O, 26
mM NaHCO3, 11.5 mM glucose, 1 mM MgSO4-7H2O, 2 mM CaCl2-H2O). Horizontal
sections were cut in ice-cold ACSF using a sapphire blade on a vibratome (Series 1000,
Ted Pella Inc, Redding CA, USA), then immediately placed into 36 °C ACSF and
bubbled with 95% O2 / 5% CO2 for at least 30 minutes to allow for cell recovery. Brain
slices were then placed in a recording tissue chamber (Warner RC27) and held in place
by a slice anchor composed of a stainless steel bridge with Lycra™ cross fibers. The
recording chamber was mounted on a heated chamber platform (Warner PH-6) with
constant flow (1.5 ml/min) of ACSF perfusing the slices throughout the recording period.
ACSF was maintained at 33-35 °C by an in-line solution heater (Warner SH-27B) with
both the platform and in-line solution heaters being regulated by a dual temperature
controller (Warner TC-344B).

The location of the VTA in the slice was visually

identified using infrared differential interference contrast (IR-DIC) microscopy at low
power (4X objective) by triangulation from anatomical landmarks including the
mammillothalamic tract, oculomoter nerve, and the substantia nigra pars compacta.
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Recording/aspiration electrodes were made from filamented glass (Sutter Instrument,
Novato CA) using a P-97 micropipette puller (Sutter Instruments) to a tip diameter of
approximately 3 microns. Intra-pipette solution consisted of (in mM): 5 NaCl, 147 KCl
20 HEPES, 1.2 MgCl2, 11 glucose and 5 Mg-ATP. Electrodes were positioned near the
cells via triple-axes piezoelectric microdrives (SD Instruments MX7630L&R). Neurons
were then characterized with whole-cell recordings in current-clamp mode via
hyperpolarizing and depolarizing currents, using an Axon Instruments Multiclamp 700A
amplifier and pClamp software suite.
In addition to the sections used for patch-clamp and aspiration of cells, a 0.7 mm
horizontal section of tissue was taken and frozen immediately on dry ice in a Petri dish.
Tissue samples of both the nucleus accumbens and VTA were taken using a 1.0 mm
tissue punch (EMS, Hatfield PA); whole parts of the brain were kept as well for control
purposes. All tissue was stored at -80ºC until further use.

Blood Alcohol Level Analysis

Immediately following decapitation of the rats, blood samples were taken and
frozen in microcentrifuge tubes at -80ºC until further analyses.

Samples were then

thawed and centrifuged at 4ºC for 40 minutes at a speed of 2000 g. The serum was
removed and analyzed immediately for alcohol content.

Blood alcohol levels were

determined using an ethanol assay (Diagnostic Chemicals, Oxford CT). Absorbance was
read with a spectrophotometer at a wavelength of 340.
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Alcohol concentration was

determined based on a standard curve analyzed at the same time as the samples.
Concentrations were then arranged on a scatter plot to see the overall range of BALs.

Single-cell RT-PCR

Neurons from control and ethanol treated rats were aspirated under visual
observation by application of suction using a 10 cc syringe attached to the recording
pipette, and were then added to a reverse transcription (RT) reaction mixture. The iScript
cDNA synthesis kit (Biorad) was used for a total volume of 10 µl per reaction. Reactions
were run at 25°C for 10 min, 42°C for 60 min, and 95°C for 5 min in a PTC-200 thermal
cycler (MJ Research Inc., Watertown MA). Reactions were then stored at -20°C until
running the PCR. A preamplification round of multiplex PCR was performed by adding
iTAQ Supermix with ROX (Biorad) and a cocktail of primers to the completed RT
reaction, for a final volume of 50 µL. The reactions were held at 94°C for 30 seconds
then cycled 20 times. Each cycle consisted of: 92°C for 15 seconds, 60°C for 20 seconds,
and 72°C for 30 seconds. One µl samples of the initial multiplex PCR were then used as
substrate for each reaction in the subsequent real-time quantitative PCR. Real-Time
quantitative PCR using gene specific primers with FAM-TAMRA TaqMan® probes
(Applied Biosystems) for Connexin-36, Scn4b, DA D2 receptor, NMDAR2B, µ-opioid
receptor, and tyrosine hydroxylase cDNA and 18s rRNA were performed using the iTaq
Supermix with ROX (Bio-Rad) with an iCycler IQ (Bio-Rad) real-time PCR System.
Samples were amplified in triplicate, together with a negative control for each subunit (an
ACSF-only aspiration taken from the brain slice recording chamber when the cells were

14

aspirated). The amplification protocol was 50°C for 2 minutes, 95°C for 5 minutes, then
50 cycles of 95°C for 15 seconds, 60°C for 20 seconds, and 72°C for 30 seconds. Cycle
threshold (Ct) values were calculated automatically by the iCycler IQ software, with
threshold values set between 5 and 20. Relative fold expression was calculated using the
2-ΔΔCT method as described in (Livak and Schmittgen 2001). The results were then
compared between groups using the unpaired two-sample for means t-test.

SDS-PAGE and Western Blot

Brain tissue from punches previously taken was homogenized using a disposable
BioMasher® in a lysis buffer containing 150mM sodium chloride, 1.0% TX-100, 50 mM
Tris, pH 8.0 and protease inhibitor cocktail (BD Biosciences, San Jose CA). Total
protein concentration was measured using the DC Protein Assay Kit (Biorad, Hercules
CA). Brain homogenate was diluted to equal concentrations, added to a reducing sample
buffer and loaded onto a 4-20% Tris-Glycine gel (Pierce, Rockford IL). Gels were run
for 45 minutes at 130 V in a running buffer (100 mM Tris, 100 mM HEPES and 3 mM
SDS) and then transferred for 90 minutes onto polyvinylidene diflouride membranes in a
transfer buffer (25 mM Tris, 192 mM glycine and 20% methanol). Following transfer,
the membranes were blocked in a blocking solution (5% non-fat dairy milk, 25 mM Tris
HCl, 150 mM NaCl and 0.05% Tween-20) and probed with primary antibodies for two
hours at room temperature. The primary antibody dilutions consisted of: GAD-6, mAb
tissue culture supernatant, neat, (DSHB, University of Iowa; a gift from Dr. Matthew
Rasband), anti-NMDAR2B 1:333 (Zymed, San Francisco CA), anti-tyrosine hydroxylase
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1:500 (Zymed, San Francisco CA), anti- µOR 1:2000 (Chemicon, Temecula CA) and
anti-DA D2 receptor (Chemicon, Temecula CA and Millipore, Billerica MA).
Immunoblots were then washed 3 times for 5 minutes each with a tris buffered saline (25
mM Tris HCl and 150 mM NaCl, pH 7.2) and probed with goat anti-mouse/rabbit
secondary antibody for one hour (Pierce, Rockford IL). Following this incubation,
membranes were again washed and soaked in SuperSignal West Pico/Femto substrate
(Pierce, Rockford IL). Visualization took place using FluorChem 8900 (Alpha Innotech)
and was subsequently analyzed for band intensity with FluorChem software. Values for
each band were based on pixel intensity and designated as an “integrated density value”
(IDV). Background was automatically subtracted. The IDVs for the ethanol diet rats
were then calculated as a percentage of the pair-fed control rats IDVs.

Immunohistochemistry

Adult male rats were sacrificed with an overdose of isoflourane and perfused with
4% formaldehyde. Brains were immediately dissected out and placed at 4ºC in 4%
formaldehyde for 1-2 hours, then transferred to 20% sucrose and kept at 4ºC until
equilibrated. A cryostat was used to make longitudinal sections 40 µm in thickness.
Sections were immediately placed on gel-coated cover slips and stored at 4ºC. To
permeabilize the tissue, a solution of 0.1 M PB, pH 7.4, containing 0.3% Triton X-100
and 10% goat serum (PBTGS) was placed on the sections for 1 hour at room temperature.
Commercially obtained antibodies were diluted in PBTGS and kept on tissue sections 2
hours-overnight at room temperature. Antibody dilutions were as follows: Gad-6, neat;
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anti-tyrosine hydroxylase 1:1000 (Affinity BioReagents, Golden CO); and anti-DA D2
Receptor 1:100 (Abcam Inc., Cambridge MA). Sections were washed 3 times for 5
minutes each with PBTGS and then covered with the secondary antibody for 1 hour.
Secondary antibody dilutions were as follows: Alexa Flour 546 goat anti-mouse IgG
(H+L) 1:500 and Alexa Flour 488 goat anti-rabbit IgG (H+L) 1:500 (Molecular Probes,
Carlsbad CA). Sections were again washed with PBTGS, 0.1 M PB and 0.05 M PB for 5
minutes each, dried, and mounted onto slides using Flouromount-G (Southern Biotech,
Birmingham AL). Slides were visualized using an Olympus FluoView FV 300 confocal
laser scanning microscope and pictures were taken at a magnification of 200x.

RESULTS

Chronic ethanol consumption: Effects on weight

The liquid ethanol diet procedure is a new approach in the Steffensen lab. As we
did not have any experience with this form of chronic ethanol treatment it was important
to replicate previous studies using the diet and assure that it was a feasible treatment
strategy that did not adversely affect the overall health of the rats. We found that
ethanol-treated rats had body weights that did not differ significantly from their pair-fed
controls (P=0.85, F(1,19)=0.036), suggesting that the chronic ethanol treatment did not
adversely affect the dietary intake of calories (Fig. 1). This is consistent with previous
studies using the Lieber-DeCarli diet and the average daily growth rate for both groups
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was approximately 5 grams per day. The average consumption of ethanol during the 3
week period for the ethanol diet rats was 10.1 g/kg/day.

Figure 1. Chronic ethanol consumption rates: Effects on weight. Ethanoltreated rats were fed a 5% v/v solution of ethanol in a liquid diet. They consumed
approximately 10.1 g/kg of ethanol/day (n=12). Pair-fed control and alcohol-fed
rats maintained similar weight gains throughout the 3 week feeding period. Both
groups had normal growth rates of approximately 5 grams/day while on the liquid
diet. There was no significant difference in weight gain between chronic ethanoltreated rats and their pair-fed controls.
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Effects of chronic ethanol treatment on ethanol inhibition of VTA GABA neuron
ICPSDs

In our first experimental run with the chronic ethanol diet we recorded VTA
GABA neurons in vivo from 4 ethanol-treated rats and their pair-fed controls. Since this
was our first run through the procedure we decided to record two rats 2-3 hours into
ethanol withdrawal and 2 rats 6-8 hours into ethanol withdrawal. In the second group of
rats, all 4 ethanol-treated rats were recorded at 6-8 hours into ethanol withdrawal. To
make sure that all of the alcohol was out of their system in the third group, we recorded
the ethanol-treated rats at 24 hours into ethanol withdrawal.
Brief, high-frequency stimulation of the internal capsule (IC) evoked VTA GABA
neurons post-stimulus spike discharges (ICPSDs) that persisted for 300-600 msec after
termination of the stimulus train (Figure 2A,B). The mean number of VTA GABA
neuron ICPSDs at 50% maximum stimulus level (200 Hz and 10 pulses) in ethanoltreated rats was 150.8 ± 24.6, which was not significantly different from pair-fed controls
(P=0.26, t(1,8)= 1.20; mean pair-fed control = 103.3 ± 28.5; n=9). We then administered
1.0 g/kg ethanol, an acute intoxicating dose of ethanol which typically reduces ICPSDs
approximately 50% (Stobbs, Ohran et al. 2004)), and recorded VTA GABA neuron
ICPSDs at 5, 10, 15, and 30 min intervals (Figure 2B,C). Although in some rats there
appeared to be tolerance to an acute dose of ethanol (Figure 2B,D), as previously
reported for firing rate (Gallegos, Criado et al. 1999), there was no significant difference
between ethanol-treated rats and pair-fed controls for acute ethanol inhibition of VTA
GABA neuron ICPSDs (P=0.44, t(1,8)=0.81; mean pair-fed % baseline= 59 ± 5 % and
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mean ethanol diet % baseline = 66 ± 8% at the 15 min time point; n=9). Please note that
ICPSD data from ethanol diet rats withdrawn for only 3 hours and their pair-fed controls
was not included in this statistical analysis.
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Figure 2. No tolerance to ethanol inhibition of VTA GABA neuron ICPSDs.
(A,B) The top inset shows a representative recording of a VTA GABA neuron
spike in a pair-fed control rat and an ethanol diet rat respectively during high
frequency stimulation of the IC (200 Hz, 10 pulses). Note that spiking extends
beyond the stimulus train for hundreds of msec. The peri-stimulus interval spike
histogram (PSH) shows the cumulated spiking associated with 12 high frequency
IC stimulation epochs demonstrating IC-evoked post-stimulus spike discharges
(ICPSDs).

(C,D) The top inset shows the same neurons following IP

administration of 1.0 g/kg ethanol, a moderately intoxicating dose. (C) This PSH
shows the effects of ethanol on cumulated ICPSDs in the pair-fed control rat.
Ethanol reduced ICPSDs about 50% at this level of ethanol as previously
reported (Stobbs, Ohran et al. 2004) (D) An acute challenge of ethanol did not
appear to affect ICPSDs as shown in the top inset and PSH of this ethanol-diet
rat. (E) This graph summarizes the effects of acute ethanol (1.0 g/kg) on VTA
GABA neuron ICPSDs in chronic ethanol treated rats vs pair-fed controls.
Although some chronic ethanol treated rats exhibited tolerance to ethanol (B,D)
there was no significant difference in acute ethanol inhibition of ICPSDs between
ethanol treated and pair-fed controls (n=9).

To ensure both the pair-fed and ethanol diet rats received adequate IP injections
of ethanol during the in vivo recording, we measured the blood alcohol levels between 30
to 70 minutes post-injection and found that the mean blood alcohol level was 48.61 ±
1.31 mg% (Figure 3). All rats showed a blood alcohol level within range of this mean,
suggesting that the IP injection was suitable.
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Figure 3. Blood Alcohol Level Distribution. Blood samples were taken from rats
after in vivo experiments were performed. Blood alcohol levels were calculated
for each rat to verify IP injection reliability. As seen here, all rats received a
substantial amount of ethanol, ensuring that injections were credible. Not all
blood samples were taken at the same time post-injection, likely accounting for
the range of BALs seen here.

Electrophysiological characterization of neurons in the VTA

VTA GABA neurons were distinguished from DA neurons by specific
electrophysiological criteria, in agreement with previous studies from other labs (Grace
1988; Grace and Onn 1989; Mercuri, Calabresi et al. 1990; Johnson and North 1992).
While this analysis was not performed on all aspirated cells, it did give another input in
addition to PCR analysis to characterize these neurons (Figure 4).
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Figure 4. Electrophysiological characterization of VTA GABA neurons in the
midbrain slice preparation. (A,B) Under current-clamp recording conditions,
VTA GABA neurons had higher input resistance measured with hyperpolarizing
currents, a more negative resting membrane potential shorter spikes (measured at
half-maximum peak amplitude) and a relative lack of spike accommodation (C,D)
compared to DA neurons. (E,F) Under voltage-clamp recording conditions, VTA
GABA neurons were characterized by a lack of hyperpolarization-driven mixed
cationic inward current (Ih) compared to DA neurons.
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Expression of select genes in dopamine versus GABA neurons: Quantitative single-cell
RT-PCR

In order to determine if differences in molecular signature exist between GABA
and DA neurons in the VTA, we evaluated the expression of select gene products in
GABA neurons and compared them to DA neurons. We evaluated the gene expression of
50 VTA GABA neurons, aspirated from the pair-fed control rats, and 25 VTA DA
neurons, aspirated from rats on a regular solid diet. Although the rats were on different
diets (solid versus liquid), it is unlikely that this variation would evoke the extremely
significant differences we saw in certain genes. Figure 5 summarizes the differences
between VTA DA and GABA neurons for the expression of TH, D2, Cx36, NMDAR2B,
and µOR mRNA transcripts.

Tyrosine hydroxylase expression in DA neurons was

significantly greater than GABA neurons (P=0.0002, t(1,23)=4.5; mean DA neuron TH
expression = 6.12 ± 0.77 and mean GABA neuron TH expression = 0.07 ± 0.01; n=33).
The cycle threshold for 18s, the housekeeping gene that was used for the quantification of
the relative expression of each of the gene products, was not significantly different
between DA and GABA neurons (P=0.35, t(1,31)=0.95; mean DA cell 18s CT = 12.53 ±
0.18 and mean GABA cell 18s CT = 12.87 ± 0.34).

The expression of D2 was

significantly greater in DA neurons than GABA neurons (P=0.019; mean DA cell D2
expression = 3.39 ± 0.59 and mean GABA cell D2 expression = 0.26 ± 0.03; n=29). The
cycle threshold for 18s was not significantly different between groups (P=0.82,
t(1,27)=0.23; mean DA cell 18s CT = 12.53 ± 0.18 and mean GABA cell 18s CT = 12.63 ±
0.35).

Connexin-36 expression in DA neurons was not significantly different than
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GABA neurons (P=0.24, t(1,15)=1.2; mean DA cell Cx36 expression = 1.68 ± 0.22 and
mean GABA cell Cx36 expression = 1.02 ± 0.19; n=17). The cycle threshold for 18s was
not significantly different between groups (P=0.88, t(1,15)=0.16; mean DA cell 18s CT =
12.71 ± 0.25 and mean GABA cell 18s CT = 12.64 ± 0.39).

The expression of

NMDAR2B was significantly greater in DA than GABA neurons (P=0.050, t(1,10)=2.2;
mean DA cell NMDAR2B expression = 5.19 ± 1.13 and mean GABA cell NMDAR2B
expression = 0.65 ± 0.22; n=17). The cycle threshold for 18s was not significantly
different between groups (P=0.77, t(1,15)=0.29; mean DA cell 18s CT = 12.81 ± 0.28 and
mean GABA cell 18s CT = 12.68 ± 0.37). Expression of µOR in DA neurons was not
significantly different than GABA neurons (P=0.59, t(1,4)=0.59; mean DA cell µOR
expression = 1.18 ± 0.33 and mean GABA cell µOR expression = 1.71 ± 0.38; n=6). The
cycle threshold for 18s was not significantly different (P=0.14, t(1,4)=1.85; mean DA cell
18s CT = 11.92 ± 0.31 and mean GABA cell CT = 13.65 ± 0.88).
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Figure 5. Expression of select genes in dopamine versus GABA neurons.
Single-cell quantitative RT-PCR was performed on neurons in the VTA of adult
male rats. Both dopamine and GABA neurons expressed TH, D2, Cx36, NR2B
and µOR transcripts. However, the expression of TH, D2 and NR2B was much
higher in DA neurons than GABA neurons. This differential expression of some
gene products may provide a way to distinguish DA and GABA neurons.

Immunohistological characterization of the VTA

In order to better understand the expression levels of the gene products analyzed
by PCR, immunoflourescent labeling of midbrain sections was performed using
antibodies against Gad-6, an enzyme precursor to GABA, TH, an enzyme precursor to
DA, and D2, a receptor located on VTA GABA neurons. As seen in Figure 6, TH
clearly labels what we assume would be DA neurons. Gad-6, while its labeling is quite
diffuse labeling both cell bodies and terminals, appears to have a complete lack of
staining for many of these cells. There are some cells though, indicated by white arrows,
where both Gad6 and TH are seen co-localized.

This co-localization provides an

explanation for the presence of TH mRNA in GABA neurons, as revealed through RTPCR. Co-labeling is also seen with D2 and Gad-6 as indicated by white arrows.
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Figure 6. Immunohistological characterization of the VTA. Tissue sections in
the area of the VTA taken from adult male rat brains were stained for the
following antibodies: Gad-6, TH and D2. (A) Gad-6 shows diffuse terminal
labeling as well as cellular labeling. TH clearly labels cell bodies in the VTA (B)
and can be seen co-labeled with Gad-6 in select neurons in (C), indicated by
arrows. Gad-6 also shows co-localization with Dopamine D2 receptors (D, E, F)
as indicated by arrows.

Effects of chronic ethanol treatment on expression of select genes in VTA GABA
neurons: Quantitative single-cell RT-PCR

In order to determine if molecular adaptation occurs with chronic ethanol, we
evaluated the expression of select gene products in VTA GABA neurons in chronic
ethanol-treated rats and compared them to pair-fed controls. We evaluated the gene
expression in 109 GABA neurons: 59 from the 12 ethanol diet rats and 50 from the 12
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pair-fed controls. Figure 7 summarizes the differences between VTA GABA neurons
from ethanol-treated rats and pair-fed controls for the expression of TH, D2, Cx36,
NMDAR2B, and µOR.

TH expression in ethanol treated rats was not significantly

different than pair-fed controls (P=0.90; mean pair-fed TH expression = 1.44 ± 0.23 and
mean ethanol diet TH expression = 2.39 ± 0.35; n=37). The cycle threshold for 18s, the
housekeeping gene that was used for the quantification of the relative expression of each
of the gene products, was not significantly different between pair-fed and ethanol diet rats
(P=0.41, t(1,35)=0.83; mean pair-fed 18s CT = 12.87 ± 0.34 and mean ethanol diet 18s CT
= 12.56 ± 0.18). The expression of D2 in ethanol treated rats was significantly less than
pair-fed controls (P=0.0068, t(1,16)=3.1; mean pair-fed D2 expression = 1.13 ± 0.14 and
mean ethanol diet D2 expression = 0.52 ± 0.06, n=18). The cycle threshold for 18s was
not significantly different between groups (P=0.08, t(1,16)=1.85; mean pair-fed 18s CT =
12.63 ± 0.35 and mean ethanol diet 18s CT = 12.02 ± 0.16). Connexin-36 expression in
ethanol treated rats was not significantly different than pair-fed controls (P=0.83,
t(1,18)=0.22; mean pair-fed Cx36 expression = 1.45 ± 0.28 and mean ethanol diet Cx36
expression = 1.62 ± 0.29; n=20). The cycle threshold for 18s was not significantly
different between groups (P=0.59, t(1,18)=0.55; mean pair-fed 18s CT = 12.64 ± 0.39 and
mean ethanol diet 18s CT = 12.90 ± 0.28). The expression of NMDAR2B in ethanol
treated rats was not significantly different than pair-fed controls (P=0.90, t(1,13)=0.12;
mean pair-fed NMDAR2B expression = 2.17 ± 0.73 and mean ethanol diet NMDAR2B
expression = 2.45 ± 0.89; n=15). The cycle threshold for 18s was not significantly
different between groups (P=0.51, t(1,13)=0.67; mean pair-fed 18s CT = 12.68 ± 0.37 and
mean ethanol diet 18s CT = 13.13 ± 0.48). Expression of the µOR in ethanol treated rats

28

was not significantly different than pair-fed controls (P=0.88, t(1,8)=0.15; mean pair-fed
µOR expression = 1.36 ± 0.30 and mean ethanol diet µOR expression = 1.53 ± 0.38;
n=10). The cycle threshold for 18s was not significantly different between groups
(P=0.19, t(1,8)=1.42; mean pair-fed 18s CT = 13.65 ± 0.88 and mean ethanol diet CT =
12.42 ± 0.43). Scn4b was expressed in only 5 neurons aspirated from the alcohol rats and
did not show up in any neurons from pair-fed control rats.

Figure 7. Effects of chronic ethanol treatment on expression of select genes in
VTA GABA neurons. Single-cell quantitative RT-PCR was performed on GABA
neurons aspirated from the VTA of chronic ethanol diet and pair-fed control rats.
While TH expression in GABA neurons was increased, it did not reach
significance.

However, there was a significant decrease in D2 receptor

expression in VTA GABA neurons of chronic ethanol-treated rats compared to
pair-fed controls. All other gene expressions were comparable for ethanol diet
and pair-fed control rats.
29

Protein Expression in the VTA

Since mRNA expression levels do not always correlate with protein expression
levels, we took tissue punches of the VTA, NAcc and whole rat brain, pooled samples for
each group and compared levels of certain proteins using western blot analysis. Proteins
that were analyzed include TH, NMDAR2B, Gad-6, µOR and D2.

While several

different D2 antibodies were tested, none produced a strong enough signal for analysis
(data not shown).

Pixel intensity for each band was determined using Flourchem

software and designated as an integrated density value (IDV). Results in Figure 8 were
calculated by making the IDV values from the ethanol diet tissue samples a percentage of
the pair-fed control IDV value. In the VTA, the ethanol diet tissue expressed as a percent
of control: 72.34% for TH, 112.7% for NMDAR2B, 78.94 % for µOR, and 107.8% for
Gad-6. In the NAcc, the ethanol diet tissue expressed as a percent of control: 91.03% for
TH, 109.6% for NMDAR2B, 111.11 % for µOR, and 96.34% for Gad-6. In the whole
brain control, the ethanol diet tissue expressed as a percent of control: 101.51% for TH,
75.53% for NMDAR2B, 82.01 % for µOR, and 89.44% for Gad-6. Tissue samples
analyzed were those taken from the contralateral side of the IC stimulation in vivo
experiment.
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Figure 8. Protein expression in ethanol treated rats as a percent of pair-fed
controls. Western blot analysis was performed on tissue taken from ethanol
treated rats and pair-fed controls. Specifically, tissue samples were taken from
the VTA, NAcc and whole rat brain, combined into corresponding groups and
homogenized for analysis. Equal amounts of protein were loaded into each well
of the gel, and following SDS-PAGE separation and transfer, PVDF membranes
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were probed for TH, NMDAR2B, µOR and GAD-6. Note there are no error bars
because the tissue samples were pooled for each brain region.
DISCUSSION

The ethanol liquid diet we chose to use, the Lieber-DeCarli diet, was critical to
the success of this project. Since it was the first time for our lab to use this procedure, we
were careful to measure consumption and weights of each rat on a regular basis. By
doing this, we were able to show that each group of rats consumed a consistent amount
that kept them on a normal growth schedule. In addition, the ethanol-diet rats consumed
approximately 10.1 g/kg/day of ethanol, an amount shown by other labs to be enough to
induce molecular changes in the brain (Lack, Floyd et al. 2005). However, because this
amount of ethanol is consumed slowly over a 24 hour period, and likely titrated by the
animal to not produce intoxication, it is questionable whether the dose was strong enough
to induce dependence and withdrawal that has been seen with twice-daily intraperitoneal
injections of ethanol (Gallegos, Criado et al. 1999). This could be due to the fact that the
rats are never forced into withdrawal periods since they have continuous access to the
ethanol. The signs of withdrawal checked for were ventromedial flexion, tail stiffness,
and abnormal gait. While there may have been tail stiffness, none of these signs stood
out as a clear indicator of withdrawal. At one point during the last group of rats, we tried
to adjust the feeding schedule for a few days to force the ethanol-diet rats to drink more
in an eight hour period before the diet was removed for 16 hours, but this only resulted in
a low amount of liquid diet consumption. In the future, the lab will have to consider how
to increase this amount of ethanol intake to a point that will induce clear signs of
withdrawal, indicating alcohol dependence, if it wants to completely match past
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experiments. This could include forced ethanol injections, gavage or inhalation. In fact,
this study is ongoing at this time. For this project, the Lieber-DeCarli diet was sufficient
for the ethanol-treated rats to be considered as chronic, though likely non-dependent.
The first physiological experiment that was performed on rats was to evaluate the
effects of acute ethanol on electrical coupling (i.e., ICPSDs) between VTA GABA
neurons in chronic ethanol-treated rats. Since we have previously demonstrated that
VTA GABA neuron firing rate adapts to an acute challenge of ethanol (Gallegos, Criado
et al. 1999), we predicted a similar result with the ICPSDs, which are normally inhibited
50% by a 1.1 g/kg dose of ethanol. While there were a few ethanol rats that seemed to
show a smaller degree of inhibition, overall there was no difference between groups in
the inhibition of ICPSDs caused by an acute ethanol injection. To make sure that each rat
received a viable injection, we took blood samples upon completion of the experiment
and measured the blood alcohol level (BAL). Ethanol elimination is first order kinetics
and is eliminated at 25 mg%/hr. Because not all the ethanol diet rats were withdrawn for
the same amount of time, it is likely that two of the twelve ethanol-diet rats recorded at 3
hours after withdrawal still had ethanol in their system while the other ten rats, recorded 8
and 24 hours after withdrawal should have been cleared of all ethanol. This variability in
withdrawal times was a pitfall for this in vivo experiment. It is well known that ethanol
withdrawal peaks around 8 hours after withdrawal, when all the alcohol is out of the
system. For this reason, we decided not to include the 3 hour withdrawn rats in the
ICPSD statistics. In future experiments, we will likely record 24 hours after withdrawal
in order to maximize effects and assure the systems are clear of alcohol in every rat in
spite of their drinking pattern. Regardless of this pitfall, we still saw variability in the
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response to acute ethanol in rats that were clearly withdrawn from ethanol. This could
mean that some rats tolerated more quickly to the ethanol, perhaps due to some genetic
influence differing between the rats. Much more work would need to be done to look
into this possibility; however, we take it as a sign that tolerance to acute ethanol
inhibition of electrical coupling might be forthcoming in rats that are clearly dependent
on ethanol. Although not an aim of my thesis, these studies are currently ongoing.
The molecular side of this project came with some discrepancies and further
characterization of DA and GABA neurons was needed, due to much controversy in the
field. Originally it was assumed that DA and GABA neurons would be distinguished by
the presence or absence of TH. However, many of the GABA neurons characterized
electrophysiologically expressed TH at a low level compared to electrophysiologically
characterized DA neurons.

In consequence of this finding, we analyzed a large of

number of DA neurons and compared them to the GABA neurons and found that they
differed significantly in the expression of TH, D2 and NMDAR2B. All three of these
were expressed in much lower levels in GABA neurons compared to DA neurons, with
TH being extremely different. While some would suggest that the finding of TH in
GABA neurons could simply be a result of contamination from surrounding cells, despite
proper controls taken, there is evidence from other labs that TH is present in GABA
neurons (Klink, Exaerde et al. 2001; Olson and Nestler 2007). To further support this
evidence, immunoflourescent experiments were performed and included staining of the
VTA in adult male rats with both TH and GAD. Evidence of co-labeling was seen (see
Figure 6). Thus, it is apparent that both DA neurons and GABA neurons are expressing
TH.

The GAD antibody we used labels both GAD65 (terminal/fiber) and GAD67
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(cellular), explaining why there is such a large amount of positive staining. It could be
that the GAD co-labeled with TH is the staining of GAD terminals on a DA neuron, but
the GAD labeling on the neuron to the right in A of Figure 6 appears to be more than just
terminal staining.
After setting a base standard to distinguish DA from GABA neurons, we were
able to more accurately analyze and compare mRNA expression levels between ethanol
diet and pair-fed control GABA neurons. Though it has been previously shown by other
labs that TH expression increases with chronic ethanol (Ortiz, Fitzgerald et al. 1995), we
did not see a significant difference between the chronic and control group. It did appear
to be higher in the chronic group but statistically, did not reach an acceptable P-value.
This lack of statistical significance could be due to various neurons that did not quite fit
in with the rest and could be remedied by running more cells (despite the large number
we already ran). We did however find that DA D2 receptor mRNA expression was
significantly lower in ethanol diet rats compared to their pair-fed controls. Although it is
well-known that DA neurons are inhibited by D2 auto-receptor activation by DA, we
have recently found that VTA GABA neurons are excited by DA via D2 receptors (paper
in submission). We have postulated that DA neurons regulate GABA neuron excitability
via DA release and D2 activation, although there is no anatomical evidence for this
synaptic arrangement in the VTA. Regardless, D2 receptor activation is an important
regulator of VTA GABA neuron excitability, as tonic firing rate of VTA GABA neurons
is nearly abolished by D2 antagonists. Thus, modulation of D2 receptors on VTA GABA
neurons by chronic ethanol is an important finding. This finding corresponds well with
findings from other labs showing up-regulation in TH, the precursor enzyme to DA.
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While a change in Cx36 expression was hypothesized, it remained at similar levels in
both groups, as did NMDAR2B and µOR. Expression of µOR was more rare than any of
these other genes and thus our sample size was small.

However, this low mRNA

expression rate did correlate with the low protein expression in the VTA as seen in
Figure 8.

One other gene that was analyzed in some of the cells was Scn4b.

Interestingly, it was only expressed in cells and bath controls from ethanol-diet rats.
While only a third of the total number of cells was analyzed for Scn4b, it is worth noting
that not a single cell or bath control from the pair-fed rats expressed Scn4b. Indeed this
may be worth further investigation in the future, but for our present purpose we chose to
dedicate the remainder of the cells for analyzing µOR expression in placement of Scn4b.
In order to compare and correlate mRNA expression with actual protein
expression in the VTA, we analyzed tissue samples taken from the VTA, NAcc and
whole brain. Since the tissue samples were so small, we combined individual samples for
all ethanol-diet and pair-fed control rats into a pools for analysis. Protein levels were
determined and loaded equally onto a gel for both groups. Though we found differences
between the various parts of the brain, we did not see any significant differences between
ethanol diet and pair-fed control samples in any part of the brain. Had we been able to
analyze each tissue punch separately and obtain a large sample size, we may have been
able to more accurately distinguish differences in band intensity. However, the band
intensity fluctuates too much in the controls for there to be any conclusions drawn from
the data. In the future, a different approach would need to be taken in order to retrieve
and maintain an adequate amount of tissue sample from a single punch so that multiple
western blots could be run for each group. We hoped to be able to correlate the D2

36

down-regulation seen using RT-PCR with down-regulation in actual protein seen by
western blot, but were not able to find a sufficient antibody to detect D2 in our tissue
samples.
While there are many unanswered questions left behind by this project, there are
several findings that are significant. The first was the configuring of the liquid diet. We
confirmed that the rats maintain healthy consistent eating habits even on a 5% ethanol
liquid diet and also determined that the rats need to be withdrawn from the ethanol for 24
hours before doing in vivo electrophysiology experiments. In addition, because there
were signs of tolerance to ethanol inhibition of ICPSDs in some rats, future studies
similar to this one would be valuable to further evaluate electrical coupling in ethanoldependent rats.

These studies are now being run in the Steffensen lab.

Another

important part of this project was determining molecular differences between VTA
GABA and DA neurons. We only looked at a few of a long list of gene products and in
the future, it would be valuable to continue this study to resolve controversy in
distinguishing GABA and DA neurons in the VTA. Most significantly, we found that
chronic ethanol for the 3 week time period induced a down-regulation of DA D2 receptor
mRNA.

This down-regulation could be part of a chain of events that leads to the

cravings that come during withdrawal and future studies should be aimed at analyzing in
depth the role of D2 receptors on VTA GABA neurons. Finally, we learned from the
protein analysis that there was no substantial change in each area of the brain for each
protein examined and that more samples need to be analyzed to obtain statistical
relevancy. In conclusion, I have found that D2 receptor expression in VTA GABA
neurons down-regulates in association with chronic ethanol diet. However, there were no
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statistically-relevant changes in VTA GABA neuron physiology in non-dependent rats. It
may be that dependence to ethanol is necessary for physiological manifestations of
tolerance in VTA GABA neurons, as well as full adaptation of gene products other than
D2. These findings will serve as a foundation for future studies in ethanol-dependent
rats, which is currently an ongoing project in the Steffensen lab.
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